AstraZeneca sued for faulty COVID-19 vaccine testing data
Posted On: Jan. 29, 2021 9:26 AM CST
A pension fund has sued U.K.-based pharmaceutical firm AstraZeneca PLC for alleged “wrongful acts and omissions” relating to the COVID-19 vaccines that resulted in losses for the investors, Livemint reported. AstraZeneca is accused of providing faulty data on the vaccine’s efficacy and its effectiveness in people aged 55 years and above that led to share price decline and losses for the investors.